MedTrace Logo

Pediatric Asthma Alert Intervention for Minority Children With Asthma

NCT00860418 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 350

Last updated 2015-09-02

No results posted yet for this study

Summary

Young inner-city children with asthma have the highest emergency department (ED) visit rates. Relying on the emergency department for asthma care can be a dangerous sign of poorly controlled asthma. This research will focus on whether having a specialized asthma nurse join the family at a child's doctor visit after an ED visit for asthma to make sure the child and parent keep the follow-up appointment and have the nurse remind the child's doctor to prescribe preventive asthma medicines and an asthma action plan for home (PAAL intervention) will result in young children with asthma having fewer days with wheezing and cough.

The investigators hypothesize that:

1. Significantly more children receiving the PAAL intervention will attend greater than 2 non-urgent visits and greater than 6 refills for the child's anti-inflammatory medications over 12 months when compared to children in the control or standard asthma education group.
2. Children in the PAAL intervention group will experience less morbidity and caregivers will experience increased quality of life compared to children in the control of standard asthma education group.

Conditions

Interventions

BEHAVIORAL

Pediatric Asthma Alert (PAAL)

Asthma nurse conducts 2 home visits and accompanies the child to primary care provider visit after ED visits

BEHAVIORAL

Standard asthma education

Standard asthma education during 2 home visits.

Sponsors & Collaborators

  • University of Maryland

    collaborator OTHER

  • University of Rochester

    collaborator OTHER

  • Johns Hopkins University

    lead OTHER

Principal Investigators

  • Arlene M Butz, ScD, RN · Johns Hopkins University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
3 Years
Max Age
10 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-09-30
Primary Completion
2013-06-30
Completion
2013-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00860418 on ClinicalTrials.gov